Health Canada approves weight-loss drug for sleep apnea in patients with obesity (opens in new tab)
TORONTO — Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity.
Read the original articleTORONTO — Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity.
Read the original article